From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.A.S, L.T., W.-Y.Y., C.-G.Y., F.-F.W., Z.-Y.Z.).
Cardiovascular Research Institute Maastricht, Maastricht University, The Netherlands (J.A.S.).
Hypertension. 2020 Mar;75(3):603-614. doi: 10.1161/HYPERTENSIONAHA.119.14217. Epub 2020 Feb 3.
Our objective was to gain insight in the calculation and interpretation of population health metrics that inform disease prevention. Using as model environmental exposure to lead (ELE), a global pollutant, we assessed population health metrics derived from the Third National Health and Nutrition Examination Survey (1988 to 1994), the GBD (Global Burden of Disease Study 2010), and the Organization for Economic Co-operation and Development. In the National Health and Nutrition Examination Survey, the hazard ratio relating mortality over 19.3 years of follow-up to a blood lead increase at baseline from 1.0 to 6.7 µg/dL (10th-90th percentile interval) was 1.37 (95% CI, 1.17-1.60). The population-attributable fraction of blood lead was 18.0% (10.9%-26.1%). The number of preventable ELE-related deaths in the United States would be 412 000 per year (250 000-598 000). In GBD 2010, deaths and disability-adjusted life-years globally lost due to ELE were 0.67 million (0.58-0.78 million) and 0.56% (0.47%-0.66%), respectively. According to the 2017 Organization for Economic Co-operation and Development statistics, ELE-related welfare costs were $1 676 224 million worldwide. Extrapolations from the foregoing metrics assumed causality and reversibility of the association between mortality and blood lead, which at present-day ELE levels in developed nations is not established. Other issues limiting the interpretation of ELE-related population health metrics are the inflation of relative risk based on outdated blood lead levels, not differentiating relative from absolute risk, clustering of risk factors and exposures within individuals, residual confounding, and disregarding noncardiovascular disease and immigration in national ELE-associated welfare estimates. In conclusion, this review highlights the importance of critical thinking in translating population health metrics into cost-effective preventive strategies.
我们的目的是深入了解用于指导疾病预防的人群健康指标的计算和解释。以全球污染物铅的环境暴露(ELE)为例,我们评估了源自第三次全国健康和营养调查(1988 年至 1994 年)、全球疾病负担研究(GBD,2010 年)和经济合作与发展组织(OECD)的数据的人群健康指标。在全国健康和营养调查中,死亡率与基线时血铅增加 19.3 年的风险比(10 到 90 分位数区间)从 1.0 增加到 6.7μg/dL(95%CI,1.17-1.60)为 1.37。血铅的人群归因分数为 18.0%(10.9%-26.1%)。美国每年因 ELE 可预防的死亡人数将为 412 000 人(250 000-598 000)。在 GBD 2010 年,全球因 ELE 导致的死亡和伤残调整生命年(DALY)损失分别为 67 万人(0.58-0.78 万)和 0.56%(0.47%-0.66%)。根据 2017 年经济合作与发展组织的统计数据,全球与 ELE 相关的福利成本为 16.762 亿美元。从上述指标推断,目前发达国家的 ELE 水平下,死亡率与血铅之间的关联具有因果关系和可逆转性,但这尚未得到证实。其他限制 ELE 相关人群健康指标解释的问题包括基于过时血铅水平的相对风险膨胀、不能区分相对风险和绝对风险、个体内部风险因素和暴露因素的聚集、残留混杂以及在国家 ELE 相关福利估计中忽略非心血管疾病和移民。总之,本综述强调了在将人群健康指标转化为具有成本效益的预防策略时进行批判性思维的重要性。